BioSpace News Archive

Pharm Country

Anavex Life Sciences Invited to Present at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference

Anavex Life Sciences Corp. announced that Christopher U Missling, PhD, President & Chief Executive Officer of Anavex will present at the B. Riley Securities’ 2022 Virtual Neuro & Ophthalmology Conference on Wednesday, April 27, 2022, at 11:00 AM ET.

April 26, 2022
·
3 min read
Business

Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022

Amicus Therapeutics announced that the Company will host a conference call and live audio webcast on Monday, May 9, 2022 at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2022.

April 26, 2022
·
1 min read
Business

Apellis Pharmaceuticals to Host Conference Call on May 4, 2022 to Discuss First Quarter 2022 Financial Results

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will host a conference call and webcast to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022 at 4:30 p.m. ET.

April 26, 2022
·
1 min read
Pharm Country

Helius Medical Technologies, Inc. Introduces Device in U.S. To Help Multiple Sclerosis Patients Improve Walking Ability

Helius Medical Technologies, Inc. announced availability in the market of its breakthrough technology with the potential to help patients in the United States with Multiple Sclerosis who struggle to walk.

April 26, 2022
·
9 min read
Business

Vedere Bio II Appoints Accomplished Clinician and Researcher Anna-Maria Demetriades as Chief Medical Officer

Vedere Bio II, Inc. today announced the appointment of Anna-Maria Demetriades , M.D., Ph.D. as Chief Medical Officer.

April 26, 2022
·
3 min read
Business

Covalon Announces New Senior Vice President of Marketing

Covalon Technologies Ltd. today announced that Ron Hebert has joined the Company as Senior Vice President of Marketing.

April 26, 2022
·
3 min read
Business

Exo Therapeutics Appoints Laura Kiessling to Scientific Advisory Board

Exo Therapeutics, Inc. today announced the appointment of Laura Kiessling, PhD, to the company’s Scientific Advisory Board (SAB).

April 26, 2022
·
3 min read
Business

Rockley Photonics Revises Date of First Quarter 2022 Financial Results Release

Rockley Photonics today announced that its first quarter 2022 financial results conference call has been rescheduled to after the market close on Thursday, May 12, 2022, to allow additional time to prepare its earnings report.

April 26, 2022
·
3 min read
Business

Rubius Therapeutics to Announce First Quarter 2022 Financial Results

Rubius Therapeutics, Inc. (Nasdaq: RUBY), today announced plans to report first quarter financial results on Tuesday, May 10, 2022, before market open.

April 26, 2022
·
1 min read
Drug Development

SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102 in Patients with Gastric and Pancreatic Cancer

SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced today that it has dosed the first patient in its Phase1/2 CLAUDIO-01 trial of SOT102 in patients with gastric and pancreatic cancer.

April 26, 2022
·
3 min read